HEPA (Hepion Pharmaceuticals, Inc.) Bathi saben saham sajrone rolas wulan pungkasan

Logo perusahaan publik Hepion Pharmaceuticals Inc. (HEPA)

Hepion Pharmaceuticals (HEPA) is accelerating the development of NASH therapy through partnerships with research centers, although development is patent-protected and requires massive capital to mitigate risks. The annual EPS TTM delta in the GURU.Markets chart shows that -5.80 represents the latest metric reading. The company's environmental strategy relies on laboratory safety and digital administration.

Hepion Pharmaceuticals, Inc. (HEPA): Bathi saben saham sajrone rolas wulan pungkasan saka 11.02.2024 nganti 20.02.2024

Hepion Pharma - rincian analitis lan metrik utama (HEPA)

- indikator valuasi pasar bisnis:
Analisis wiwitan perusahaan:Hepion Pharmaceuticals Inc.
Sampel barang Hepion Pharmaceuticals Inc.

This indicator measures the dynamics of rolling net income, reflecting the rate of change in real earnings per share over a year. Investors utilize the current YoY ttm net income per share growth to determine market value momentum and assess overbought risks. A negative trend signals a degradation of fundamental metrics. For Hepion Pharmaceuticals (HEPA), this is confirmed by the collapse of clinical trials for its primary drug. The company is currently urgently cutting expenses to preserve its remaining capital.